BIOMAT Database Logo BIOMAT Database Logo

[The laser therapy of patients with hypertension in combination with coronary insufficiency]. 1996

T A Kniazeva, and V A Badtieva, and S M Zubkova

Hypertensive patients with coronary insufficiency have received infrared (lambda = 0.85 microns) laser radiation to the skin. The treatment is shown to have antianginal, antihypertensive effects, to improve cardiac performance, myocardial contractility, to increase myocardial, coronary and aerobic reserves. This clinicofunctional efficacy is accompanied by positive shifts in lipid metabolism, lipid peroxidation activity, antioxidant defense, hemocoagulation and microcirculation.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007259 Infrared Rays That portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants. Heat Waves,Heat Wave,Infrared Ray,Ray, Infrared,Rays, Infrared,Wave, Heat,Waves, Heat
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

T A Kniazeva, and V A Badtieva, and S M Zubkova
[Therapy of arterial hypertension with coronary insufficiency].
June 1973, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
February 1977, Zeitschrift fur arztliche Fortbildung,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Changes in central hemodynamics and microcirculation during laser therapy in patients with coronary insufficiency].
January 1993, Kardiologiia,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Neodicoumarin therapy of patients with coronary insufficiency].
January 1956, Sovetskaia meditsina,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Chloracizine therapy of patients with coronary insufficiency].
June 1961, Klinicheskaia meditsina,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Laser puncture in the combination therapy of pregnancy nephropathy combined with hypertension].
June 1985, Akusherstvo i ginekologiia,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Thrombin activity in the blood of patients with coronary insufficiency and hypertension].
February 1968, Terapevticheskii arkhiv,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Differentiated therapy of patients with chronic coronary insufficiency].
April 1969, Terapevticheskii arkhiv,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[Experimental drug therapy with hexonium of hypertension and coronary insufficiency in monkeys].
January 1957, Farmakologiia i toksikologiia,
T A Kniazeva, and V A Badtieva, and S M Zubkova
[The therapy of coronary insufficiency and cardiac arrhythmias with an ajmaline combination preparation].
September 1960, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!